Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

ClinicalTrials.gov ID: NCT06735534

Public ClinicalTrials.gov record NCT06735534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.

Study identification

NCT ID
NCT06735534
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
376 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 3, 2025 (Actual)
Primary completion
Apr 2027 (Estimated)
Completion
Jan 2028 (Estimated)
Last update posted
Sep 24, 2026

2025 – 2028

United States locations

U.S. sites
33
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
Mobile Infirmary Medical Center Mobile Alabama 36607 —
Arrhythmia Research Group-Research Facility Jonesboro Arkansas 72401 —
University of Southern California Hospital Los Angeles California 90033 —
St. John's Regional Medical Center Oxnard California 93030 —
Stanford University Medical Center Stanford California 94305 —
South Denver Cardiology Associates, PC Littleton Colorado 80120 —
HCA Florida Mercy Hospital Miami Florida 33133 —
Naples Comprehensive Health Naples Florida 34102 —
AdventHealth Orlando-Hospital Orlando Florida 32803 —
Tampa General Hospital Tampa Florida 33606 —
AdventHealth Tampa-Hospital Tampa Florida 33613 —
Emory University Hospital Atlanta Georgia 30322 —
Atrium Health Navicent The Medical Center Macon Georgia 32201 —
Memorial Health University Medical Center Savannah Georgia 31404 —
St. Luke's Boise Medical Center Boise Idaho 83712 —
Advocate Christ Medical Center-Hospital Oak Lawn Illinois 60453 —
Johns Hopkins Hospital Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Southcoast Physicians Group Fall River Massachusetts 02720 —
William Beaumont Hospital-Hospital Royal Oak Michigan 48073 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Virtua Health Inc. Marlton New Jersey 08053 —
Lovelace Medical Center Albuquerque New Mexico 87102 —
Northwell Health Manhasset New York 11030 —
Weill Cornell Medical University New York New York 10065 —
Bethesda North Hospital Cincinnati Ohio 45242 —
Ohio State University Medical Center Columbus Ohio 43210 —
Oklahoma Heart Institute Tulsa Oklahoma 74104 —
Trident Medical Center Charleston South Carolina 29406 —
Texas Cardiac Arrhythmia Research Austin Texas 78705 —
Christus Trinity Mother Frances Health System Tyler Texas 75701 —
St. Mark's Hospital Salt Lake City Utah 84124 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06735534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06735534 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →